Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;22(8):953-61.
doi: 10.1007/s00192-011-1401-8. Epub 2011 Apr 13.

Differential profile analysis of urinary cytokines in patients with overactive bladder

Affiliations

Differential profile analysis of urinary cytokines in patients with overactive bladder

Gamal Ghoniem et al. Int Urogynecol J. 2011 Aug.

Erratum in

  • Int Urogynecol J. 2011 Aug;22(8):1069

Abstract

Introduction and hypothesis: We hypothesize that overactive bladder (OAB) can produce inflammatory cytokines due to afferent neural plasticity or urothelial dysfunction. This study aimed to detect abnormal cytokine levels in urine of patients with OAB compared to urinary tract infections (UTI) and controls.

Methods: This was a prospective, single blind study including 20 premenopausal women (control), 20 with OAB and 16 with UTI. Urine samples were collected, centrifuged, and stored (-80°C). Urinary total proteins were quantified and detected by antibody-based array chip for release of 120 human cytokines in the two groups relative to the controls.

Results: Majority of cytokines showed the same expression in the OAB compared with the controls. Cytokines exclusively expressed in OAB were: monocyte chemoattractant protein (MCP) 1, TARC, PARC, and Fas/TNFRSF6. MCP-2, MCP-3, tumor necrosis factor-β, GCSF and eotaxin-3 showed a shared expression in UTI and OAB. Conversely, few of the cytokines were downregulated in OAB (IL-5, IL-6, IL-7, and GM-CSF).

Conclusions: Taken together, the results suggest that a subset of inflammatory cytokines and chemokines provides a framework for development of highly optimized urinary biomarker assay for differential diagnosis and treatment of OAB.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. J Urol. 2001 Sep;166(3):1111-8 - PubMed
    1. Br J Urol. 1998 Jul;82(1):118-21 - PubMed
    1. J Urol. 2006 May;175(5):1624-9 - PubMed
    1. J Urol. 2004 Jan;171(1):462-6 - PubMed
    1. J Urol. 2008 Jun;179(6):2270-4 - PubMed

Publication types

LinkOut - more resources